Urology · El Paso, TX
NPI
1033222906
Since 2006
Specialty
Urology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
7420 Remcon Cir, Bldg A
El Paso, TX, 79912
Phone (915) 532-8823
Groups this clinician bills Medicare through
Medicare paid, 2024
$622K
11,431 services
Medicare patients, 2024
749
Average age 75
Drug cost, 2024
$10.3M
3,521 prescriptions
Company payments, 2025
$29K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey M Spier was code J0897 (injection, denosumab, 1 mg), 5,820 times for 35 patients. In total Jeffrey M Spier billed 11,431 services in 88 codes, and Medicare paid $622K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-06-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 5,820 | 35 | $20.79 | $121K |
| 99214 Office E&M - Established | Office | 496 | 344 | $98.93 | $49K |
| 81001 Clinical Chemistry | Office | 470 | 350 | $3.04 | $1,431 |
| 99213 Office E&M - Established | Office | 326 | 268 | $66.15 | $22K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 180 | 26 | $141.82 | $26K |
| 51798 Ultrasound - Nonspecific | Office | 149 | 129 | $8.21 | $1,223 |
| 87798 Infectious Agent Detection by DNA/RNA | Office | 137 | 19 | $33.45 | $4,583 |
| 99212 Office E&M - Established | Office | 116 | 108 | $39.10 | $4,535 |
| 96372 Injection Administration | Office | 91 | 51 | $11.52 | $1,048 |
| 99215 Office E&M - Established | Office | 82 | 57 | $147.13 | $12K |
| 52000 Cystourethroscopy | Office | 74 | 61 | $189.57 | $14K |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 70 | 66 | $82.37 | $5,766 |
| 96402 Chemotherapy Administration | Office | 57 | 35 | $28.32 | $1,614 |
| 99204 Office E&M - New | Office | 49 | 49 | $111.54 | $5,465 |
| 99203 Office E&M - New | Office | 32 | 32 | $85.17 | $2,726 |
By year: 2022 $196K for 5,259 services; 2023 $166K for 4,215 services; 2024 $622K for 11,431 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81001 Clinical Chemistry | 470 | 350 | $3.04 | $1,431 |
| 87798 Infectious Agent Detection by DNA/RNA | 137 | 19 | $33.45 | $4,583 |
| P9612 Catheterization for collection of specimen, single patient, all places of service | 30 | 27 | $8.65 | $260 |
| 36415 Venipuncture Blood Collection | 20 | 20 | $8.65 | $173 |
| 87653 Infectious Agent Detection by DNA/RNA | 19 | 19 | $31.02 | $589 |
| 87640 Infectious Agent Detection by DNA/RNA | 18 | 18 | $32.64 | $587 |
| 87500 Infectious Agent Detection by DNA/RNA | 12 | 12 | $29.05 | $349 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey M Spier prescribed most often to Medicare patients was Tamsulosin Hcl, with 792 prescriptions and refills. In total Jeffrey M Spier wrote 3,521 Medicare prescriptions that cost $10.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 792 | 2,215 | 283 | $13K |
| Erleada Apalutamide | 350 | 364 | 56 | $5.2M |
| Finasteride Generic | 330 | 964 | 115 | $4,242 |
| Ciprofloxacin Hcl Generic | 308 | 310 | 224 | $1,667 |
| Orgovyx Relugolix | 229 | 229 | 41 | $595K |
| Xtandi Enzalutamide | 154 | 158 | 33 | $2.2M |
| Solifenacin Succinate Generic | 150 | 402 | 72 | $7,470 |
| Nubeqa Darolutamide | 144 | 144 | 30 | $1.9M |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 118 | 125 | 90 | $3,074 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 94 | 94 | 77 | $583 |
| Myrbetriq Mirabegron | 85 | 196 | 45 | $87K |
| Prednisone Generic | 70 | 74 | 15 | $187 |
| Abiraterone Acetate Generic | 60 | 60 | Under 11 | $64K |
| Cefuroxime Cefuroxime Axetil | 57 | 60 | 46 | $754 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 52 | 62 | 38 | $433 |
Brand drugs: - claims; generic drugs: 2,458 claims; opioid claims: 110.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey M Spier $29K ($29K in general payments such as food, travel and fees) from 24 companies. The largest payer was Novartis Pharmaceuticals Corporation with $15K.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 17 | $15K |
| Boston Scientific Corporation BSX | 7 | $6,792 |
| Pfizer Inc. PFE | 10 | $1,749 |
| Calyxo, Inc. | 9 | $1,555 |
| Dendreon Pharmaceuticals LLC | 13 | $568 |
| Janssen Biotech, Inc. JNJ | 25 | $551 |
| Cardinal Health 414 LLC | 1 | $530 |
| Bioprotect Medical, Inc. | 2 | $451 |
| Astellas Pharma US Inc 4503.T | 17 | $403 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $276 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.